Nexentis Technologies Inc. (NXTS)
NASDAQ: NXTS · Real-Time Price · USD
3.710
-0.479 (-11.42%)
Apr 8, 2026, 4:00 PM EDT - Market closed

Nexentis Technologies Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3.831.924.455.76.75
Short-Term Investments
0.240.31---
Cash & Short-Term Investments
4.072.234.455.76.75
Cash Growth
82.56%-49.85%-21.99%-15.56%2679.31%
Accounts Receivable
0.130.140.110.190.17
Other Receivables
0.40.23---
Total Trade Receivables
0.530.370.110.190.17
Inventory
--0.120.080.02
Other Current Assets
1.410.820.790.30.28
Total Current Assets
6.013.455.476.277.23
Net Property, Plant & Equipment
0.040.010.120.220.23
Other Intangible Assets
4.43----
Goodwill
6.29----
Long-Term Investments
2.741.411.66--
Other Long-Term Assets
0.890.59--0.14
Total Assets
20.415.477.246.497.6
Accounts Payable
0.010.020.040.420.54
Short-Term Debt
0.74---0.01
Other Current Liabilities
0.690.770.740.30.38
Total Current Liabilities
1.430.890.780.710.93
Long-Term Debt
0.24----
Long-Term Leases
0.01-0.010.040.09
Other Long-Term Liabilities
3---0.17
Total Long-Term Liabilities
3.24-0.010.040.25
Total Liabilities
4.680.890.790.751.18
Common Stock
---00
Additional Paid-in Capital
54.6139.3335.8728.7123.61
Accumulated Other Comprehensive Income
-0.04-0.03-0.03-0.03-0.03
Retained Earnings
-38.56-34.55-29.36-22.84-17.1
Total Common Shareholders' Equity
16.014.756.485.856.48
Minority Interest
-0.28-0.18-0.02-0.11-0.07
Shareholders' Equity
15.734.576.465.746.41
Total Liabilities & Equity
20.415.477.246.497.6
Total Debt
0.9900.010.040.1
Net Cash (Debt)
3.092.234.445.666.66
Net Cash Growth
38.39%-49.78%-21.56%-14.94%-
Net Cash Per Share
2.4011.91129.44374.70695.91
Book Value
16.014.756.485.856.48
Book Value Per Share
12.4325.37188.91386.99677.93
Tangible Book Value
5.294.756.485.856.48
Tangible Book Value Per Share
4.1125.37188.91386.99677.93
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.